Organon stockholders approve 8 million share increase to 2021 incentive stock plan
At its June 9, 2026 Annual Meeting, Organon stockholders approved an amended and restated 2021 Incentive Stock Plan that adds 8,000,000 shares available for issuance. Stockholders also elected all ten director nominees and ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal 2026, so the outcome is a routine annual meeting with an equity plan change that adds potential share issuance.
Key points
- The amended and restated 2021 Incentive Stock Plan was approved at the June 9, 2026 Annual Meeting and adds 8,000,000 shares for issuance.
- All ten director nominees were elected to serve until the 2027 annual meeting; Ramona Sequeira received the most For votes at 146,867,855.
- In a non-binding advisory vote, named executive officer compensation received 142,593,022 For votes and 7,311,933 Against votes.
- PricewaterhouseCoopers LLP was ratified for fiscal year 2026 with 196,889,135 For votes and 4,100,954 Against votes.
The filing
Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 11, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.